Categories: NewsVaccine

Award-Winning Film An Inconvenient Study Sparks Global Debate on Vaccine Safety and Chronic Disease

Following its viral global premiere, ICAN and Del Bigtree release a response to media criticisms of the unpublished vaccinated-versus-unvaccinated study featured in the film

AUSTIN, Texas, Oct. 23, 2025 (GLOBE NEWSWIRE) — The award-winning film An Inconvenient Study has been seen by millions following its global premiere on October 12th, sparking international discussion and debate about vaccine safety, scientific transparency, and the alarming rise in chronic illness among America’s children.

Produced by the Informed Consent Action Network (ICAN) and Emmy Award–winning journalist Del Bigtree, the film investigates an unpublished vaccinated-versus-unvaccinated study conducted within the prestigious Henry Ford Health System.

In 2016, Bigtree challenged Dr. Marcus Zervos, head of infectious disease at Henry Ford, to conduct a rigorous comparison of vaccinated and unvaccinated children and to publish the results regardless of outcome. Dr. Zervos accepted, conducted the study, and later declined to submit it for publication. On hidden camera, he admits, “I think it’s a good study… but publishing something like that — might as well retire. I’d be finished.”

Following widespread media coverage, including criticism from Henry Ford, The Conversation, and Stat News, ICAN has released a response addressing their criticisms.

“We address these criticisms not because we must,” said ICAN in its published statement, “but because science demands debate. Every study should be challenged, discussed, and improved — without fear of professional reprisal.” Read the full response at https://www.aninconvenientstudy.com/criticisms

A Call for Scientific Transparency

An Inconvenient Study exposes the broader public health crisis that has seen rates of chronic illness in American schoolchildren soar from roughly 12% in 1986 to over 50% today. The film urges greater transparency, independent research, and true informed consent in public health policy.

“This isn’t about being pro or anti anything,” said Bigtree. “It’s about asking why our kids are so sick — and ensuring science remains open to honest inquiry.”

An Inconvenient Study is now available to stream globally, free of charge, at AnInconvenientStudy.com.
ICAN’s response to media criticisms can be found HERE.

MEDIA CONTACT:
Tracy Diaz
Tracy@thehighwire.com
(321) 345-6932
www.AnInconvenientStudy.com

Executive Producer Del Bigtree is available for interviews on this topic he sees as vital to the discussion around the childhood chronic disease epidemic in America.

Staff

Recent Posts

Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures

SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- BiOS - Hall D Booth #8430, Photonics West Hall…

6 hours ago

DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

11 hours ago

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

12 hours ago

University of Phoenix and LinkedIn to host webinar on AI in nursing with skills and strategies for a new era of healthcare

January 22 virtual event "AI in Action: Skills and Strategies for a New Era of…

12 hours ago

Instinct Science Acquires ScribbleVet to Deliver the Next Generation of Intelligent-Native Veterinary Practice Management Software

The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system…

12 hours ago

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

17 hours ago